Belite Bio, Inc Operating Lease, Right-of-Use Asset, Amortization Expense
Belite Bio, Inc (BLTE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $280.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-03-31
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|
| 2025-12-31 | $280.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $281.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $260.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $134.00K 20-F · filed 2025-03-17 |
| 2021-12-31 | $0.00 20-F · filed 2024-03-12 |